Stem cells as in vitro model of Parkinson's disease

Stem Cells International

Volumn , Issue , 2012, Pages

  Martínez Morales, Patricia L ^a   Liste, Isabel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN;

CELL ACTIVITY; CELL FUNCTION; CELL KINETICS; CELL LOSS; CELL THERAPY; CYTOLOGY; DISEASE COURSE; DISEASE MODEL; DJ1 GENE; DOPAMINERGIC NERVE CELL; DRUG DEVELOPMENT; DRUG SCREENING; DRUG TARGETING; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; LRRK2 GENE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MULTIPOTENT STEM CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NONHUMAN; PARK1 GENE; PARK2 GENE; PARK4 GENE; PARK5 GENE; PARK6 GENE; PARK8 GENE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PINK1 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECESSIVE GENE; REVIEW; SNCA GENE; SOMATIC CELL; STEM CELL; TOTIPOTENT STEM CELL;

EID: 84861043528     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2012/980941     Document Type: Review

References (45)

1. Arenas E., Towards stem cell replacement therapies for Parkinson's disease Biochemical and Biophysical Research Communications 2010 396 1 152 156
2. Lees A. J., Hardy J., Revesz T., Parkinson's disease The Lancet 2009 373 9680 2055 2066
3. Jankovic J., Parkinson's disease: clinical features and diagnosis Journal of (Pubitemid 351441488)
4. Lindvall O., Kokaia Z., Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease Trends in Pharmacological Sciences 2009 30 5 260 267
5. Lindvall O., Bjrklund A., Cell Therapeutics in Parkinson's Disease Neurotherapeutics 2011 8 4 539 548
6. Mendez I., Viuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J. Q., Isacson O., Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years Nature Medicine 2008 14 5 507 509 (Pubitemid 351655215)
7. Piccini P., Brooks D. J., Bjrklund A., Gunn R. N., Grasby P. M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., Lindvall O., Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient Nature Neuroscience 1999 2 12 1137 1140 (Pubitemid 30126374)
8. Wood-Kaczmar A., Gandhi S., Wood N. W., Understanding the molecular causes of Parkinson's disease Trends in Molecular Medicine 2006 12 11 521 528 (Pubitemid 44633809)
9. Vekrellis K., Xilouri M., Emmanouilidou E., Rideout H. J., Stefanis L., Pathological roles of -synuclein in neurological disorders The Lancet Neurology 2011 10 11 1015 1025
10. Drolet R. E., Sanders J. M., Kern J. T., Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions Journal of Neurogenetics 2011 25 4 140 151
11. Dodson M. W., Guo M., Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease Current Opinion in Neurobiology 2007 17 3 331 337 (Pubitemid 46880329)
12. Corti O., Lesage S., Brice A., What genetics tells us about the causes and mechanisms of Parkinson's disease Physiological Reviews 2011 91 4 1161 1218
13. Hardy J., Genetic analysis of pathways to parkinson disease Neuron 2010 68 2 201 206
14. Durnaoglu S., Genc S., Genc K., Patient-specific pluripotent stem cells in neurological diseases Stem Cells International 2011 2011 17
15. Marchetto M. C. N., Winner B., Gage F. H., Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases Human Molecular Genetics 2010 19 1 R71 R76
16. Zeng X., Chen J., Deng X., Liu Y., Rao M. S., Cadet J. L., Freed W. J., An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP + toxicity and GDNF neuroprotection Neuropsychopharmacology 2006 31 12 2708 2715 (Pubitemid 44764167)
17. Thomson J. A., Itskovitz-Eldor J., Shapiro S. S., Embryonic stem cell lines derived from human blastocysts Science 1998 282 5391 1145 1147 (Pubitemid 28516247)
18. Kriks S., Shim J. -W., Piao J., Ganat Y. M., Wakeman D. R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., Yang L., Beal M. F., Surmeier D. J., Kordower J. H., Tabar V., Studer L., Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease Nature 2011 480 7378 547 551
19. Malmersj S., Liste I., Dyachok O., Tengholm A., Arenas E., Uhlén P., Ca 2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons Stem Cells and Development 2010 19 9 1355 1364
20. Chambers S. M., Fasano C. A., Papapetrou E. P., Tomishima M., Sadelain M., Studer L., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nature Biotechnology 2009 27 3 275 280
21. Perrier A. L., Tabar V., Barberi T., Rubio M. E., Bruses J., Topf N., Harrison N. L., Studer L., Derivation of midbrain dopamine neurons from human embryonic stem cells Proceedings of the National Academy of Sciences of the United States of America 2004 101 34 12543 12548 (Pubitemid 39122060)
22. Park I. H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M. W., Cowan C., Hochedlinger K., Daley G. Q., Disease-specific induced pluripotent stem cells Cell 2008 134 5 877 886
23. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S., Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors Cell 2007 131 5 861 872 (Pubitemid 350138099)
24. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells Science 2007 318 5858 1917 1920
25. Martnez-Serrano A., Liste I., Recent progress and challenges for the use of stem cell derivatives in neuron replacement therapy for Parkinsons disease Future Neurology 2010 5 2 161 165
26. Villa A., Liste I., Courtois E. T., Seiz E. G., Ramos M., Meyer M., Juliusson B., Kusk P., Martnez-Serrano A., Generation and properties of a new human ventral mesencephalic neural stem cell line Experimental Cell Research 2009 315 11 1860 1874
27. Sonntag K. C., Pruszak J., Yoshizaki T., van Arensbergen J., Sanchez-Pernaute R., Isacson O., Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin Stem Cells 2007 25 2 411 418 (Pubitemid 46232796)
28. Cooper O., Hargus G., Deleidi M., Blak A., Osborn T., Marlow E., Lee K., Levy A., Perez-Torres E., Yow A., Isacson O., Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid Molecular and Cellular Neuroscience 2010 45 3 258 266
29. Sanchez-Pernaute R., Lee H., Patterson M., Reske-Nielsen C., Yoshizaki T., Sonntag K. C., Studer L., Isacson O., Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease Brain 2008 131 8 2127 2139
30. Nguyen H. N., Byers B., Cord B., Shcheglovitov A., Byrne J., Gujar P., Kee K., Schle B., Dolmetsch R. E., Langston W., Palmer T. D., Pera R. R., LRRK2 mutant iPSC-derived da neurons demonstrate increased susceptibility to oxidative stress Cell Stem Cell 2011 8 3 267 280
31. Devine M. J., Ryten M., Vodicka P., Thomson A. J., Burdon T., Houlden H., Cavaleri F., Nagano M., Drummond N. J., Taanman J. -W., Schapira A. H., Gwinn K., Hardy J., Lewis P. A., Kunath T., Parkinson's disease induced pluripotent stem cells with triplication of the -synuclein locus Nature Communications 2011 2 1, article 440
32. Hargus G., Cooper O., Deleidi M., Levy A., Lee K., Marlow E., Yow A., Soldner F., Hockemeyer D., Hallett P. J., Osborn T., Jaenisch R., Isacson O., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats Proceedings of the National Academy of Sciences of the United States of America 2010 107 36 15921 15926
33. Wernig M., Zhao J. P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R., Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 15 5856 5861 (Pubitemid 351758462)
34. Swistowski A., Peng J., Liu Q., Mali P., Rao M. S., Cheng L., Zeng X., Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions Stem Cells 2010 28 10 1893 1904
35. Prakash N., Wurst W., Development of dopaminergic neurons in the mammalian brain Cell Tissue Research 2004 63 187 206
36. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., Ericson J., Identification of intrinsic determinants of midbrain dopamine neurons Cell 2006 124 2 393 405 (Pubitemid 43121986)
37. Friling S., Andersson E., Thompson L. H., Jonsson M. E., Hebsgaard J. B., Nanou E., Alekseenko Z., Marklund U., Kjellander S., Volakakis N., Hovatta O., Manira A. E., Bjcirklund A., Perlman T., Ericson J., Efficient production of mesencephalic dopamine neurons by Lmxla expression in embryonic stem cells Proceedings of the National Academy of Sciences of the United States of America 2009 106 18 7613 7618
38. Caiazzo M., Dell'Anno M. T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T. D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R. R., Gustincich S., Dityatev A., Broccoli V., Direct generation of functional dopaminergic neurons from mouse and human fibroblasts Nature 2011 476 7359 224 227
39. Pfisterer U., Kirkeby A., Torper O., Wood J., Nelander J., Dufour A., Bjrklund A., Lindvall O., Jakobsson J., Parmar M., Direct conversion of human fibroblasts to dopaminergic neurons Proceedings of the National Academy of Sciences of the United States of America 2011 108 25 10343 10348
40. Ferri A. L. M., Lin W., Mavromatakis Y. E., Wang J. C., Sasaki H., Whitsett J. A., Ang S. L., Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner Development 2007 134 15 2761 2769 (Pubitemid 47307232)
41. Snchez-Danés A., Consiglio A., Richaud Y., Rodrguez-Piz I., Dehay B., Edel M., Bové J., Memo M., Vila M., Raya A., Izpisua Belmonte J. C., Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells Human Gene Therapy 2012 23 1 56 69
42. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G. W., Cook E. G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., Jaenisch R., Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors Cell 2009 136 5 964 977
43. Soldner F., Laganire J., Cheng A. W., Hockemeyer D., Gao Q., Alagappan R., Khurana V., Golbe L. I., Myers R. H., Lindquist S., Zhang L., Guschin D., Fong L. K., Vu B. J., Meng X., Urnov F. D., Rebar E. J., Gregory P. D., Zhang H. S., Jaenisch R., Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations Cell 2011 146 2 318 331
44. Narendra D. P., Youle R. J., Targeting mitochondrial dysfunction: role for PINK1 and parkin in mitochondrial quality control Antioxidants and Redox Signaling 2011 14 10 1929 1938
45. Seibler P., Graziotto J., Jeong H., Simunovic F., Klein C., Krainc D., Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells Journal of Neuroscience 2011 31 16 5970 5976